#OrphanDrugDesignation
OBI’s TROP2 ADC OBI-902 has been granted Orphan Drug Designation by the U.S. FDA for the treatment of cholangiocarcinoma, a rare and aggressive cancer with limited treatment options.
#OBIPharma #OBI902 #ADC #OrphanDrugDesignation #Cholangiocarcinoma

www.accessnewswire.com/newsroom/en/...
www.accessnewswire.com
November 18, 2025 at 12:13 AM